Search results with tag "Cd47"

Lemzoparlimab: A Differentiated CD47 Mab in Clinical Study

Preliminary efficacy assessment (cutoff Nov 10, 2020) Figure data cut off: Nov 10 2020 Poster data cut off: Sep 11 2020 SD PR SD SD * ** § One confirmed PR in 30mg/kg cohort (n=3). § Three patients achieved SD (stable disease). * One showed reduction of 25% at first scan (10mg/kg). ** One with SD (15% reduction) continued on therapy (30mg/kg)

  Assessment, Preliminary, Differentiated, Lemzoparlimab, A differentiated cd47, Cd47